BoxOne Ventures — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane Hegarty(Executive Officer)Shane V. Hegarty(Chief Scientific Officer & Co-Founder)Jeffrey Imbaro(Executive Officer)Joanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)Tiasha Shafiq(Chief of Staff)
Co-investorsvenBio PartnersMRL Ventures FundSofinnova VenturesCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+7 more
Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system.
BiotechDeep TechSemiconductorsBoston, US
Jeffrey Abbott(Co-Founder & CEO)Vince Wu(Co-Founder & CTO)Duane Sword(Co-Founder & CBO)inDonhee Ham(Scientific Co-Founder)Hongkun Park(Scientific Co-Founder)Vince (Wenxuan) Wu(Founder)in
Co-investorsAnzu PartnersLYFE CapitalBantam GroupDraper Associates
Revalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development.
AI & Machine LearningBiotechHealthtechNew Haven, US
Greg Tietjen(Co-Founder & Chief Executive Officer)inJenna DiRito(Co-Founder)Kourosh Saeb-Parsy(Co-Founder)Helen Hughes(Co-Founder & Chief People Officer)Peter Buniak(Co-Founder & Advisor)Jenna DiRito, PhD(Founder)in
Co-investorsAmerica's Frontier FundConnecticut InnovationsDniproSierra VenturesEntrepreneur First
Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts.
AI & Machine LearningBiotechDeep TechHealthtechSeattle, US
Alex Federation(Founder)inLindsay Pino(Founder)in
BoardOmri Amirav-Drory(Director)inJ. Seth Strattan(Director)in
Co-investorsFarvatn VentureFifty YearsFundersClubNFXTwo Bear CapitalY Combinator
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.